Episodes
Thursday Aug 29, 2019
E45: TNF or TCZ or ABA or RTX: Real World Data for RA
Thursday Aug 29, 2019
Thursday Aug 29, 2019
This week I tackle an interesting cohort study that Jack Cush (@RheumNow) mentioned in his podcast. It's a nice opportunity to discuss bDMARDs in the "real world" (AKA Sweden). Follow me @ebrheum and let me know what you think of the episode!
Thursday Aug 15, 2019
E44: SELECT-COMPARE Upadacitinib (JAKi) for Rheumatoid Arthritis
Thursday Aug 15, 2019
Thursday Aug 15, 2019
Finally got around to tackling the JAKi this week. I decided to focus on SELECT-COMPARE, which pitted upadacitinib (selective JAK1 inhibitor) against adalimumab and placebo. I briefly discuss other JAKs and my thoughts on the future of this area. Get the paper and others at ebrheum.com and follow me @ebrheum!
Thursday Aug 08, 2019
E43: Tofacitinib for MDA5 Amyopathic Dermatomyositis ILD
Thursday Aug 08, 2019
Thursday Aug 08, 2019
Back this week to discuss an interesting paper in the NEJM. Lots of interesting issues, most notably historical controls and their limitations. Find all my work at ebrheum.com!